利用蜡样芽孢杆菌新型焦酰基转移酶强化2′-焦酰基乳糖生物合成途径。

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-04-30 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1569597
Kainuo Zhang, Miaomiao Gao, Chenqi Cao, Mengxin Zhang, Waqar Ahmad, Ahmed Rady, Badr Aldahmash, Tianze Zhu, Shahin Shah Khan, Luo Liu
{"title":"利用蜡样芽孢杆菌新型焦酰基转移酶强化2′-焦酰基乳糖生物合成途径。","authors":"Kainuo Zhang, Miaomiao Gao, Chenqi Cao, Mengxin Zhang, Waqar Ahmad, Ahmed Rady, Badr Aldahmash, Tianze Zhu, Shahin Shah Khan, Luo Liu","doi":"10.3389/fbioe.2025.1569597","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>2'-Fucosyllactose (2'-FL) is an oligosaccharide that can be synthesized in the human body and is known for its health-promoting and prebiotic effects. The biosynthesis of 2'-FL using microorganisms has received attention recently due to its increased application in nutritional and medical infant formulations.</p><p><strong>Methods: </strong>This work attempts the new application of <i>Bacillus cereus</i> α-1,2-fucosyltransferase (FutCB) in the <i>de novo</i> synthesis of 2'-FL in <i>Escherichia coli</i> (<i>E. coli</i>). Additionally, knocking out the <i>LacZ</i> and <i>WaaF</i> genes alongside overexpression of the key gmd, manB, wcaG, and manC genes enhances the availability of the necessary precursors GDP-L-fucose and lactose for the synthesis of 2'-FL.</p><p><strong>Results and discussion: </strong>The use of constitutive promoters achieved better control over the production of 2'-FL during fed-batch fermentation. After 64 h of fermentation, the modified <i>E. coli</i> strains produced 121.4 g/L 2'-FL with a yield of 1.90 g/L/h, resulting in an impressive 2'-FL output. These results together indicate the potential of large-scale, high-yield production of 2'-FL and form a basis of much more refinement to be done. The next step will focus on maximum substrate utilization, alteration of gene regulation, and improvement of commercial-scale synthesis.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1569597"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12075129/pdf/","citationCount":"0","resultStr":"{\"title\":\"Intensification of 2'-Fucosyllactose biosynthesis pathway by using a novel fucosyltransferase from <i>Bacillus cereus</i>.\",\"authors\":\"Kainuo Zhang, Miaomiao Gao, Chenqi Cao, Mengxin Zhang, Waqar Ahmad, Ahmed Rady, Badr Aldahmash, Tianze Zhu, Shahin Shah Khan, Luo Liu\",\"doi\":\"10.3389/fbioe.2025.1569597\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>2'-Fucosyllactose (2'-FL) is an oligosaccharide that can be synthesized in the human body and is known for its health-promoting and prebiotic effects. The biosynthesis of 2'-FL using microorganisms has received attention recently due to its increased application in nutritional and medical infant formulations.</p><p><strong>Methods: </strong>This work attempts the new application of <i>Bacillus cereus</i> α-1,2-fucosyltransferase (FutCB) in the <i>de novo</i> synthesis of 2'-FL in <i>Escherichia coli</i> (<i>E. coli</i>). Additionally, knocking out the <i>LacZ</i> and <i>WaaF</i> genes alongside overexpression of the key gmd, manB, wcaG, and manC genes enhances the availability of the necessary precursors GDP-L-fucose and lactose for the synthesis of 2'-FL.</p><p><strong>Results and discussion: </strong>The use of constitutive promoters achieved better control over the production of 2'-FL during fed-batch fermentation. After 64 h of fermentation, the modified <i>E. coli</i> strains produced 121.4 g/L 2'-FL with a yield of 1.90 g/L/h, resulting in an impressive 2'-FL output. These results together indicate the potential of large-scale, high-yield production of 2'-FL and form a basis of much more refinement to be done. The next step will focus on maximum substrate utilization, alteration of gene regulation, and improvement of commercial-scale synthesis.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1569597\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12075129/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1569597\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1569597","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:2'- focusyllactose (2'- fl)是一种可以在人体内合成的低聚糖,具有促进健康和益生元作用。利用微生物生物合成2'-FL最近受到关注,因为它在营养和医疗婴儿配方中的应用越来越多。方法:本工作尝试了蜡样芽孢杆菌α-1,2-聚焦转移酶(FutCB)在大肠杆菌(E. coli)中重新合成2′- fl的新应用。此外,敲除LacZ和WaaF基因以及关键的gmd、manB、wcaG和manC基因的过表达,增强了2'- fl合成所需的前体GDP-L- focal和乳糖的可用性。结果与讨论:在分批补料发酵过程中,使用组成型启动子可以更好地控制2′-FL的产生。经过64 h的发酵,改良的大肠杆菌菌株产生121.4 g/L的2'-FL,产量为1.90 g/L/h,产生了令人印象深刻的2'-FL。这些结果共同表明了2′-FL大规模高产生产的潜力,并为进一步改进奠定了基础。下一步的重点是最大限度地利用底物,改变基因调控,提高商业规模的合成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Intensification of 2'-Fucosyllactose biosynthesis pathway by using a novel fucosyltransferase from Bacillus cereus.

Introduction: 2'-Fucosyllactose (2'-FL) is an oligosaccharide that can be synthesized in the human body and is known for its health-promoting and prebiotic effects. The biosynthesis of 2'-FL using microorganisms has received attention recently due to its increased application in nutritional and medical infant formulations.

Methods: This work attempts the new application of Bacillus cereus α-1,2-fucosyltransferase (FutCB) in the de novo synthesis of 2'-FL in Escherichia coli (E. coli). Additionally, knocking out the LacZ and WaaF genes alongside overexpression of the key gmd, manB, wcaG, and manC genes enhances the availability of the necessary precursors GDP-L-fucose and lactose for the synthesis of 2'-FL.

Results and discussion: The use of constitutive promoters achieved better control over the production of 2'-FL during fed-batch fermentation. After 64 h of fermentation, the modified E. coli strains produced 121.4 g/L 2'-FL with a yield of 1.90 g/L/h, resulting in an impressive 2'-FL output. These results together indicate the potential of large-scale, high-yield production of 2'-FL and form a basis of much more refinement to be done. The next step will focus on maximum substrate utilization, alteration of gene regulation, and improvement of commercial-scale synthesis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信